Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention

References

• CannonCPBraunwaldEMcCabeCHIntensive versus moderate lipid lowering with statins after acute coronary syndromesN Engl J Med20043501495150415007110
   PubMed Web of Science ®Google Scholar
• MerlaRReddyNKWangFUretskyBFBarbagelataABirnbaumYMeta-analysis of published reports on the effect statin treatment before percutaneous coronary intervention on periprocedural myonecrosisAm J Cardiol200710077077617719318
   PubMed Web of Science ®Google Scholar
• PasceriVPattiGNuscaAARMYDA InvestigatorsRandomized trial of atorvastatin for reduction of myocardial damage during coronary intervention: results from the ARMYDA (atorvastatin for reduction of myocardial damage during angioplasty) studyCirculation200411067467815277322
   PubMed Web of Science ®Google Scholar
• BriguoriCViscontiGFocaccioANovel approaches for preventing or limiting events (Naples) II trial: impact of a single high loading dose of atorvastatin on periprocedural myocardial infarctionJ Am Coll Cardiol200954232157216319664895
   PubMed Web of Science ®Google Scholar
• Di SciascioGPattiGPasceriVGaspardoneAColonnaGMontinaroAEfficacy of atorvastatin reload in patients on chronic statin therapy undergoing percutaneous coronary intervention: results of the ARMYDA-RECAPTURE (atorvastatin for reduction of myocardial damage during angioplasty) randomized trialJ Am Coll Cardiol200954655856519643320
   PubMed Web of Science ®Google Scholar
• KreutzRPFlockhartDAAmlodipine-not a significant contributor to clopidogrel non-response?Heart201399743743923315611
   PubMed Web of Science ®Google Scholar
• StoneGWWitzenbichlerBWeiszGADAPT-DES InvestigatorsPlatelet reactivity and clinical outcomes after coronary artery implantation of drug-eluting stents (ADAPT-DES): a prospective multicentre registry studyLancet2013382989261462323890998
   PubMed Web of Science ®Google Scholar
• LauWCWaskellLAWatkinsPBAtorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation: a new drug-drug interactionCirculation2003107323712515739
   PubMed Web of Science ®Google Scholar
• MullerIBestaFSchulzCZhongyanLMassbergSGawazMEffects of statins on platelet inhibition by a high loading dose of clopidogrelCirculation20031082195219714568892
   PubMed Web of Science ®Google Scholar
• VinholtPPoulsenTSKorsholmLThe antiplatelet effect of clopidogrel is not attenuated by statin treatment in stable patients with ischemic heart diseaseThromb Haemost200594243844316113837
   PubMed Web of Science ®Google Scholar
• SawJBrennanDMSteinhublSRLack of evidence of a clopidogrel-statin interaction in the CHARISMA trialJ Am Coll Cardiol20075029129517659194
   PubMed Web of Science ®Google Scholar
• KreutzRPTantryUSBlidenKPGurbelPAInflammatory changes during the ‘common cold’ are associated with platelet activation and increased reactivity of platelets to agonistsBlood Coagul Fibrinolysis20071871371817982310
   PubMed Web of Science ®Google Scholar
• KreutzRPOwensJBreallJAC-reactive protein and fibrin clot strength measured by thrombelastography after coronary stentingBlood Coagul Fibrinolysis201324332132623429252
   PubMed Web of Science ®Google Scholar
• ThygesenKAlpertJSWhiteHDJoint ESC/ACCF/AHA/WHF Task Force for the Redefinition of Myocardial InfarctionUniversal definition of myocardial infarctionCirculation2007116222634265317951284
   PubMed Web of Science ®Google Scholar
• StoneNJRobinsonJGLichtensteinAHAmerican College of Cardiology/American Heart Association Task Force on Practice Guidelines2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice GuidelinesCirculation201412925 suppl 2S1S4524222016
   PubMed Web of Science ®Google Scholar
• FaridNASmallDSPayneCDEffect of atorvastatin on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel in healthy subjectsPharmacotherapy200828121483149419025429
   PubMed Web of Science ®Google Scholar
• PellicciaFRosanoGMarazziGPharmacodynamic effects of atorvastatin versus rosuvastatin in coronary artery disease patients with normal platelet reactivity while on dual antiplatelet therapy – the PEARL randomized cross-over studyEur J Pharmacol2014725182224444439
   PubMed Web of Science ®Google Scholar
• ParkYJeongYHTantryUSAccelerated platelet inhibition by switching from atorvastatin to a non-CYP3A4-metabolized statin in patients with high platelet reactivity (ACCEL-STATIN) studyEur Heart J201233172151216222507978
   PubMed Web of Science ®Google Scholar
• KimGBKimJKParkSEffect of atorvastatin and clopidogrel co-administration after coronary stenting in Korean patients with stable anginaKorean Circ J2011411283321359066
   PubMed Web of Science ®Google Scholar
• MitsiosJVPapathanasiouAIRodisFIElisafMGoudevenosJATselepisADAtorvastatin does not affect the antiplatelet potency of clopidogrel when it is administered concomitantly for 5 weeks in patients with acute coronary syndromesCirculation20041091335133815023882
   PubMed Web of Science ®Google Scholar
• WenaweserPWindeckerSBillingerMEffect of atorvastatin and pravastatin on platelet inhibition by aspirin and clopidogrel treatment in patients with coronary stent thrombosisAm J Cardiol20079935335617261397
   PubMed Web of Science ®Google Scholar
• GorchakovaOvon BeckerathNGawazMAntiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coronary artery stentingEur Heart J2004251898190215522468
   PubMed Web of Science ®Google Scholar
• SternRHGibsonDMWhitfieldLRCimetidine does not alter atorvastatin pharmacokinetics or LDL-cholesterol reductionEur J Clin Pharmacol19985364754789551707
   PubMed Web of Science ®Google Scholar
• LeonciniMTosoAMaioliMHigh-dose atorvastatin on the pharmacodynamic effects of double-dose clopidogrel in patients undergoing percutaneous coronary interventions: the ACHIDO (atorvastatin and clopidogrel high dose in stable patients with residual high platelet activity) studyJACC Cardiovasc Interv20136216917923428009
   PubMed Web of Science ®Google Scholar
• TektenTCeyhanCErcanEOnbasiliAOTurkogluCThe effect of atorvastatin on platelet function in patients with coronary artery diseaseActa Cardiol200459331131515255464
   PubMed Web of Science ®Google Scholar
• TirnaksizEPamukcuBOflazHNisanciYEffect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart diseaseJ Thromb Thrombolysis2009271242817917708
   PubMed Web of Science ®Google Scholar
• PellicciaFRosanoGMarazziGPharmacodynamic comparison of pitavastatin versus atorvastatin on platelet reactivity in patients with coronary artery disease treated with dual antiplatelet therapyCirc J201478367968424389597
   PubMed Web of Science ®Google Scholar
• OjeifoOWiviottSDAntmanEMConcomitant administration of clopidogrel with statins or calcium-channel blockers: insights from the TRITON-TIMI 38 (trial to assess improvement in therapeutic outcomes by optimizing platelet inhibition with prasugrel-thrombolysis in myocardial infarction 38)JACC Cardiovasc Interv20136121275128124239201
   PubMed Web of Science ®Google Scholar
• SawJSteinhublSRBergerPBCREDO InvestigatorsLack of adverse clopidogrel-atorvastatin clinical interaction from secondary analysis of a randomized, placebo-controlled clopidogrel trialCirculation200310892192412925453
   PubMed Web of Science ®Google Scholar